Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.94 - $1.94 $940 - $1,940
1,000 New
1,000 $1,000
Q1 2022

May 02, 2022

SELL
$1.54 - $3.71 $1,540 - $3,710
-1,000 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$0.36 - $0.95 $360 - $950
1,000 New
1,000 $0
Q3 2020

Nov 13, 2020

SELL
$0.36 - $0.53 $360 - $530
-1,000 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$0.56 - $1.62 $560 - $1,620
1,000 New
1,000 $0
Q4 2019

Jan 29, 2020

SELL
$0.83 - $1.3 $1,660 - $2,600
-2,000 Closed
0 $0
Q3 2019

Oct 10, 2019

SELL
$0.97 - $1.94 $970 - $1,940
-1,000 Reduced 33.33%
2,000 $2,000
Q2 2019

Jul 15, 2019

SELL
$1.81 - $2.45 $2,353 - $3,185
-1,300 Reduced 30.23%
3,000 $6,000
Q1 2019

Apr 12, 2019

BUY
$2.3 - $3.27 $3,633 - $5,166
1,580 Added 58.09%
4,300 $11,000
Q3 2018

Oct 22, 2018

BUY
$3.4 - $4.84 $9,248 - $13,164
2,720 New
2,720 $13,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $158M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.